Responses
Poster Presentation
Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
Compose a Response to This Article
Other responses
No responses have been published for this article.
